1. Home
  2. LGL vs CGTX Comparison

LGL vs CGTX Comparison

Compare LGL & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGL
  • CGTX
  • Stock Information
  • Founded
  • LGL 1917
  • CGTX 2007
  • Country
  • LGL United States
  • CGTX United States
  • Employees
  • LGL N/A
  • CGTX N/A
  • Industry
  • LGL Industrial Machinery/Components
  • CGTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • LGL Technology
  • CGTX Health Care
  • Exchange
  • LGL Nasdaq
  • CGTX Nasdaq
  • Market Cap
  • LGL 31.5M
  • CGTX 30.0M
  • IPO Year
  • LGL N/A
  • CGTX 2021
  • Fundamental
  • Price
  • LGL $6.62
  • CGTX $0.64
  • Analyst Decision
  • LGL
  • CGTX Strong Buy
  • Analyst Count
  • LGL 0
  • CGTX 6
  • Target Price
  • LGL N/A
  • CGTX $8.30
  • AVG Volume (30 Days)
  • LGL 5.5K
  • CGTX 891.3K
  • Earning Date
  • LGL 03-31-2025
  • CGTX 03-25-2025
  • Dividend Yield
  • LGL N/A
  • CGTX N/A
  • EPS Growth
  • LGL 66.76
  • CGTX N/A
  • EPS
  • LGL 0.07
  • CGTX N/A
  • Revenue
  • LGL $4,130,000.00
  • CGTX N/A
  • Revenue This Year
  • LGL N/A
  • CGTX N/A
  • Revenue Next Year
  • LGL N/A
  • CGTX N/A
  • P/E Ratio
  • LGL $97.35
  • CGTX N/A
  • Revenue Growth
  • LGL 26.49
  • CGTX N/A
  • 52 Week Low
  • LGL $4.86
  • CGTX $0.34
  • 52 Week High
  • LGL $6.99
  • CGTX $2.95
  • Technical
  • Relative Strength Index (RSI)
  • LGL 55.84
  • CGTX 43.76
  • Support Level
  • LGL $6.40
  • CGTX $0.60
  • Resistance Level
  • LGL $6.98
  • CGTX $0.82
  • Average True Range (ATR)
  • LGL 0.30
  • CGTX 0.06
  • MACD
  • LGL -0.02
  • CGTX -0.02
  • Stochastic Oscillator
  • LGL 68.92
  • CGTX 18.56

About LGL LGL Group Inc. (The)

LGL Group Inc is a holding company engaged in services, merchant investment and manufacturing business activities. The company has two reportable segments; Electronic Instruments and Merchant Investment. The Electronic Instruments segment, which generates key revenue, is focused on designing and manufacturing high-performance Frequency and Time reference standards that form the basis for timing and synchronization in various applications including satellite communication, time transfer systems, network synchronization, electricity distribution, and metrology. The Merchant Investment segment comprises various investment vehicles in which the company invests its capital.

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

Share on Social Networks: